Tilray is a healthcare company primarily focused on the production and distribution of cannabis products for medical and recreational use. Its core offerings include dried cannabis, oils, and edibles. The company operates in various segments, including medical cannabis, adult-use cannabis, and international markets. Major revenue sources stem from product sales in these segments, with a growing emphasis on expanding its global footprint.
The investment profile of Tilray suggests it may be more suitable for value investors, given its current financial challenges and lack of dividends. The stock exhibits high volatility, indicating potential risks that may deter growth-focused investors. A balanced approach could be considered, but the overall outlook remains cautious due to recent performance metrics.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-05-08 15:28 | — | Sell | scenario_deterioration |
| 2026-05-08 05:26 | Sell | Sell | scenario_deterioration |
| 2026-03-21 08:01 | Hold | Sell | scenario_deterioration |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-01-20 14:05 | Roth Capital | Target Lowered | 20 → 10 | 8.935 |
| 2026-01-09 12:17 | Industrial Alliance Securities | Target Lowered | 20 → 10 | 9.13 |
| 2025-12-19 12:54 | Bernstein | Target Raised | 1 → 10 | 12.34 |
